Takeda Pharmaceutical Company Limited (TAK)
USD 13.11
(-1.87%)
USD 13.11
(-1.87%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 4263.76 Billion JPY | 5.87% |
| 2023 | 4027.47 Billion JPY | 12.85% |
| 2022 | 3569 Billion JPY | 11.61% |
| 2021 | 3197.81 Billion JPY | -2.84% |
| 2020 | 3291.18 Billion JPY | 56.93% |
| 2019 | 2097.22 Billion JPY | 18.45% |
| 2018 | 1770.53 Billion JPY | 2.22% |
| 2017 | 1732.05 Billion JPY | -4.17% |
| 2016 | 1807.37 Billion JPY | 1.66% |
| 2015 | 1777.82 Billion JPY | 5.09% |
| 2014 | 1691.68 Billion JPY | 8.63% |
| 2013 | 1557.26 Billion JPY | 3.2% |
| 2012 | 1508.93 Billion JPY | 6.31% |
| 2011 | 1419.38 Billion JPY | -3.18% |
| 2010 | 1465.96 Billion JPY | -4.7% |
| 2009 | 1538.33 Billion JPY | 11.9% |
| 2008 | 1374.8 Billion JPY | 5.34% |
| 2007 | 1305.16 Billion JPY | 7.67% |
| 2006 | 1212.2 Billion JPY | 7.95% |
| 2005 | 1122.96 Billion JPY | 3.36% |
| 2004 | 1086.43 Billion JPY | 3.86% |
| 2003 | 1046.08 Billion JPY | 4.08% |
| 2002 | 1005.06 Billion JPY | 4.32% |
| 2001 | 963.48 Billion JPY | 4.37% |
| 2000 | 923.13 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1058.61 Billion JPY | 14.95% |
| 2024 Q3 | 1111.18 Billion JPY | 6.53% |
| 2024 FY | 4263.76 Billion JPY | 5.87% |
| 2024 Q4 | 1050.86 Billion JPY | -5.43% |
| 2024 Q2 | 1043.08 Billion JPY | -2.65% |
| 2023 Q1 | 972.46 Billion JPY | 11.36% |
| 2023 Q3 | 1096.55 Billion JPY | 9.4% |
| 2023 FY | 4027.47 Billion JPY | 12.85% |
| 2023 Q4 | 956.15 Billion JPY | -12.8% |
| 2023 Q2 | 1002.3 Billion JPY | 3.07% |
| 2022 FY | 3569 Billion JPY | 11.61% |
| 2022 Q3 | 901.29 Billion JPY | 6.68% |
| 2022 Q1 | 949.6 Billion JPY | 23.28% |
| 2022 Q4 | 873.28 Billion JPY | -3.11% |
| 2022 Q2 | 844.81 Billion JPY | -11.03% |
| 2021 Q2 | 788.93 Billion JPY | -1.61% |
| 2021 Q3 | 836.75 Billion JPY | 6.06% |
| 2021 Q4 | 770.27 Billion JPY | -7.94% |
| 2021 FY | 3197.81 Billion JPY | -2.84% |
| 2021 Q1 | 801.85 Billion JPY | 3.91% |
| 2020 Q1 | 849.12 Billion JPY | 18.39% |
| 2020 Q3 | 859.31 Billion JPY | 5.95% |
| 2020 Q4 | 771.7 Billion JPY | -10.2% |
| 2020 FY | 3291.18 Billion JPY | 56.93% |
| 2020 Q2 | 811.04 Billion JPY | -4.48% |
| 2019 Q3 | 499.4 Billion JPY | 15.93% |
| 2019 Q4 | 717.21 Billion JPY | 43.61% |
| 2019 FY | 2097.22 Billion JPY | 18.45% |
| 2019 Q2 | 430.77 Billion JPY | -4.24% |
| 2019 Q1 | 449.83 Billion JPY | 12.19% |
| 2018 Q2 | 433.17 Billion JPY | -3.36% |
| 2018 FY | 1770.53 Billion JPY | 2.22% |
| 2018 Q4 | 400.96 Billion JPY | -17.86% |
| 2018 Q3 | 488.15 Billion JPY | 12.69% |
| 2018 Q1 | 448.24 Billion JPY | 7.7% |
| 2017 Q1 | 434 Billion JPY | 4.8% |
| 2017 FY | 1732.05 Billion JPY | -4.17% |
| 2017 Q4 | 416.2 Billion JPY | -10.5% |
| 2017 Q3 | 465.04 Billion JPY | 11.58% |
| 2017 Q2 | 416.79 Billion JPY | -3.97% |
| 2016 Q1 | 446.29 Billion JPY | 1.93% |
| 2016 FY | 1807.37 Billion JPY | 1.66% |
| 2016 Q3 | 489.2 Billion JPY | 6.87% |
| 2016 Q2 | 457.75 Billion JPY | 2.57% |
| 2016 Q4 | 414.12 Billion JPY | -15.35% |
| 2015 Q3 | 488.63 Billion JPY | 11.0% |
| 2015 FY | 1777.82 Billion JPY | 5.09% |
| 2015 Q4 | 437.83 Billion JPY | -10.4% |
| 2015 Q2 | 440.2 Billion JPY | 7.07% |
| 2015 Q1 | 411.14 Billion JPY | 1.57% |
| 2014 Q2 | 417.73 Billion JPY | 1.81% |
| 2014 Q3 | 458.82 Billion JPY | 9.83% |
| 2014 Q4 | 404.81 Billion JPY | -11.77% |
| 2014 FY | 1691.68 Billion JPY | 8.63% |
| 2014 Q1 | 410.3 Billion JPY | 11.45% |
| 2013 Q4 | 368.15 Billion JPY | -8.46% |
| 2013 FY | 1557.26 Billion JPY | 3.2% |
| 2013 Q1 | 398.29 Billion JPY | 4.45% |
| 2013 Q2 | 388.64 Billion JPY | -2.42% |
| 2013 Q3 | 402.17 Billion JPY | 3.48% |
| 2012 Q1 | 357.21 Billion JPY | 5.61% |
| 2012 Q4 | 381.32 Billion JPY | -10.3% |
| 2012 Q3 | 425.1 Billion JPY | 23.12% |
| 2012 Q2 | 345.28 Billion JPY | -3.34% |
| 2012 FY | 1508.93 Billion JPY | 6.31% |
| 2011 Q4 | 338.25 Billion JPY | -7.86% |
| 2011 Q1 | 354.69 Billion JPY | 4.93% |
| 2011 Q2 | 359.32 Billion JPY | 1.31% |
| 2011 Q3 | 367.1 Billion JPY | 2.16% |
| 2011 FY | 1419.38 Billion JPY | -3.18% |
| 2010 FY | 1465.96 Billion JPY | -4.7% |
| 2010 Q3 | 372.49 Billion JPY | -1.06% |
| 2010 Q2 | 376.47 Billion JPY | -0.66% |
| 2010 Q4 | 338.01 Billion JPY | -9.25% |
| 2010 Q1 | 378.97 Billion JPY | 12.93% |
| 2009 Q4 | 335.57 Billion JPY | -15.18% |
| 2009 FY | 1538.33 Billion JPY | 11.9% |
| 2009 Q2 | 410.25 Billion JPY | 0.0% |
| 2009 Q3 | 395.62 Billion JPY | -3.57% |
| 2008 FY | 1374.8 Billion JPY | 5.34% |
| 2007 FY | 1305.16 Billion JPY | 7.67% |
| 2006 FY | 1212.2 Billion JPY | 7.95% |
| 2005 FY | 1122.96 Billion JPY | 3.36% |
| 2004 FY | 1086.43 Billion JPY | 3.86% |
| 2003 FY | 1046.08 Billion JPY | 4.08% |
| 2002 FY | 1005.06 Billion JPY | 4.32% |
| 2001 FY | 963.48 Billion JPY | 4.37% |
| 2000 FY | 923.13 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.39 Billion USD | -178031.247% |
| Bausch Health Companies Inc. | 8.75 Billion USD | -48589.757% |
| Catalent, Inc. | 4.38 Billion USD | -97223.944% |
| Emergent BioSolutions Inc. | 1.04 Billion USD | -406243.467% |
| Elanco Animal Health Incorporated | 4.41 Billion USD | -96430.722% |
| Perrigo Company plc | 4.65 Billion USD | -91483.512% |
| Teva Pharmaceutical Industries Limited | 15.84 Billion USD | -26807.497% |
| Zoetis Inc. | 8.54 Billion USD | -49803.581% |